The GABA(A) receptor complex as a target for fluoxetine action

Neurochem Res. 1999 Oct;24(10):1271-6. doi: 10.1023/a:1020977123968.

Abstract

The clinically important antidepressant fluoxetine is established as a selective serotonin reuptake inhibitor. This study demonstrates that fluoxetine also interacts with the GABA(A) receptor complex. At concentrations above 10 microM fluoxetine inhibited the binding of both [3H]GABA (IC50 = 2 mM) and [3H]flunitrazepam (IC50 = 132 microM) to the GABA(A) receptor complex in brain cortical membranes. Low fluoxetine concentrations (1 nM) enhanced GABA-stimulated Cl- uptake by a rat cerebral cortical vesicular preparation. At higher concentrations (100 microM and 1 mM), however, fluoxetine inhibited GABA-stimulated Cl- uptake, an effect related to a reduction in Emax. These observations might assist in an explanation of the basis of the antidepressant action of fluoxetine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Chlorides / metabolism
  • Dose-Response Relationship, Drug
  • Flunitrazepam / metabolism
  • Fluoxetine / pharmacology*
  • Ion Transport
  • Male
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, GABA-A / drug effects*
  • Selective Serotonin Reuptake Inhibitors / pharmacology*
  • Tritium
  • gamma-Aminobutyric Acid / metabolism

Substances

  • Chlorides
  • Receptors, GABA-A
  • Serotonin Uptake Inhibitors
  • Fluoxetine
  • Tritium
  • gamma-Aminobutyric Acid
  • Flunitrazepam